2,088
Views
9
CrossRef citations to date
0
Altmetric
Hematology

Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States

, , , , &
Pages 762-769 | Received 07 Mar 2018, Accepted 19 Apr 2018, Published online: 06 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Keziah Cook, Shaun P. Forbes, Kelly Adamski, Janice J. Ma, Anita Chawla & Louis P. Garrison$suffix/text()$suffix/text(). (2020) Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A. Journal of Medical Economics 23:5, pages 501-512.
Read now
Anisha M. Patel, Shelby L. Corman, Stephen Chaplin, Karina Raimundo & Robert F. Sidonio. (2019) Economic impact model of delayed inhibitor development in patients with hemophilia a receiving emicizumab for the prevention of bleeding events. Journal of Medical Economics 22:12, pages 1328-1337.
Read now
Massimo Morfini & Carlo Antonio Paolo Rapisarda. (2019) Safety of recombinant coagulation factors in treating hemophilia. Expert Opinion on Drug Safety 18:2, pages 75-85.
Read now

Articles from other publishers (6)

Deborah A. Marshall, Brittany Gerber, Diane L. Lorenzetti, Karen V. MacDonald, Riley Jewel Bohach & Gillian R. Currie. (2023) Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies. PharmacoEconomics 41:12, pages 1563-1588.
Crossref
Jing Dong, Jie Li, Ling Yang, Qiuhong Kong, Zhirong Zhang & Hong Zhang. (2022) Correlation Analysis of DNA Methylation in the von Willebrand Factor Promoter Region and the Risk of Unexplained Recurrent Hemophilia: Systematic Review and Meta-Analysis. Contrast Media & Molecular Imaging 2022, pages 1-9.
Crossref
Shermarke Hassan, Erna C. van Balen, Cees Smit, Evelien P. Mauser‐Bunschoten, Lize F.D. van Vulpen, Jeroen Eikenboom, Erik A.M. Beckers, Louise Hooimeijer, Paula F. Ypma, Laurens Nieuwenhuizen, Michiel Coppens, Saskia E.M. Schols, Frank W.G. Leebeek, Mariëtte H. Driessens, Frits R. Rosendaal, Johanna G. van der Bom & Samantha C. Gouw. (2021) Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019. Journal of Thrombosis and Haemostasis 19:10, pages 2394-2406.
Crossref
Estelle K. Ronayne, Shaun C. Peters, Joseph S. Gish, Celena Wilson, H. Trent Spencer, Christopher B. Doering, Pete Lollar, P. Clint SpiegelJrJr & Kenneth C. Childers. (2021) Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor. Frontiers in Immunology 12.
Crossref
Daniela Pilunni, Lorenzo Montrasio & Pierluigi Navarra. (2019) When innovation goes fast. The case of hemophilia. Current Opinion in Pharmacology 45, pages 95-101.
Crossref
Courtney D. Thornburg. (2018) How I approach: Previously untreated patients with severe congenital hemophilia A. Pediatric Blood & Cancer 65:12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.